Countries like India stand to benefit from the move and Merck has already granted the necessary licenses.
The £87million ($120million) is part of the foundation’s ongoing effort to support vaccine access, research and development, and drug manufacturing worldwide.
The foundation has already provided some £1.45billion ($1.9billion) in funding since the start of the pandemic.
Melinda French, the foundation’s co-chair and Bill Gates’s former wife, said: “To end this pandemic, we need to ensure that everyone, no matter where they live in the world, has access to life-saving health products.
“The unjust reality, however, is that low-income countries have had to wait for everything from personal protective equipment to vaccines. That is unacceptable.
READ MORE: Covid Plan B: Restrictions not ruled out as Delta Plus sparks panic